Paolo Fundaro, Director at INTERCEPT PHARMACEUTICALS INC (ICPT), sold 582 shares at $285.00 ($166K) on 2015-07-24, disclosed to the SEC on 2015-07-24.
Scheduled sale ($166k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ICPT | SELL | 2019-03-29 | $467K | — | Filing → |
| ICPT | SELL | 2014-08-12 | $78K | — | Filing → |
| ICPT | SELL | 2014-05-09 | $75K | — | Filing → |